A Phase 1 Study of Sgnb7h4v in Advanced Solid Tumors
Research payments
$1,344,189
Through program year 2025, $1,344,189 in research payments was reported against A Phase 1 Study of Sgnb7h4v in Advanced Solid Tumors, across 196 payments, paid by Pfizer Inc..
- Paid by
- Pfizer Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,161,704 | 181 |
| 2024 | Research | $182,485 | 15 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Cesar Perez Orlando, FL Named on 33 payments
- Erika Hamilton Nashville, TN Named on 28 payments
- Jason Henry Denver, CO Named on 28 payments
- Nehal Lakhani Grand Rapids, MI Named on 24 payments
- Guru Sonpavde Orlando, FL Named on 20 payments
- Gerardo Colon-Otero Jacksonville, FL Named on 13 payments
- Jennifer Diamond Aurora, CO Named on 10 payments
- Justin Call West Valley City, UT Named on 8 payments
- Bert Oneil Indianapolis, IN Named on 7 payments
- Jason Henry Augusta, GA Named on 5 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.